Naproxen

Product manufactured by Redpharm Drug, Inc.

Application Nr Approved Date Route Status External Links
ANDA091416 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Carefully Consider The Potential Benefits And Risks Of Naproxen And Other Treatment Options Before Deciding To Use Naproxen Tablets. Use The Lowest Effective Dose For The Shortest Duration Consistent With Individual Patient Treatment Goals (see Warnings: Gastrointestinal Bleeding, Ulceration, And Perforation). Naproxen Tablets Are Indicated: For The Relief Of The Signs And Symptoms Of Rheumatoid Arthritis. For The Relief Of The Signs And Symptoms Of Osteoarthritis For The Relief Of The Signs And Symptoms Of Ankylosing Spondylitis For The Relief Of The Signs And Symptoms Of Juvenile Arthritis Naproxen Tablets Are Also Indicated: For Relief Of The Signs And Symptoms Of Tendonitis For Relief Of The Signs And Symptoms Of Bursitis For Relief Of The Signs And Symptoms Of Acute Gout For The Management Of Pain For The Management Of Primary Dysmenorrhea

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Naproxen NAPROXEN ZINC105216

Comments